Bone drug Zometa helps fight breast cancer spread
(AP)
<p><img src="http://d.yimg.com/us.yimg.com/p/ap/20080601/capt.aab299681d8649448cf29da048d4211c.switzerland_novartis_breast_cancer_ny108.jpg?x=130&y=94&q=85&sig=qPWXpUEl5rhrm91.TIUq2Q--" align="left" height="94" width="130" alt="The headquarters of Swiss pharmaceutical company Novartis in Basel, Switzerland, are seen in this file picture taken Aug. 12, 2006. A drug to prevent bone loss during breast cancer treatment also substantially cut the risk that the cancer would return, results that left doctors excited about a possible new way to fight the disease. The study was led by Dr. Michael Gnant of the Medical University of Vienna and reported Saturday May 31, 2008 at an American Society of Clinical Oncology conference in Chicago. (AP Photo/Keystone, Steffen Schmidt, FILE)" border="0" /> (http://us.rd.yahoo.com/dailynews/rss/health/*http://news.yahoo.com/s/ap/20080601/ap_on_he_me/med_breast_cancer_bone_drug)AP - A drug to prevent bone loss during breast cancer treatment also substantially cut the risk that the cancer would return, results that left doctors excited about a possible new way to fight the disease.</p><br clear="all"/>
http://us.rd.yahoo.com/dailynews/rss/health/*http://news.yahoo.com/s/ap/20080601/ap_on_he_me/med_breast_cancer_bone_drug